Clinical complaints of daytime sleepiness and fatigue: How to distinguish and treat them, especially when they become 'excessive' or 'chronic'?

Acta Neurologica Belgica

Volumn 110, Issue 1, 2010, Pages 15-25

  Neu, Daniel ^a   Linkowski, Paul ^b   Le Bon, Olivier ^a,c  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c ULB   (Belgium)

Author keywords

Excessive daytime sleepiness; Fatigue; Review; Semiology; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; METHYLPHENIDATE; MODAFINIL;

ANXIETY DISORDER; BEHAVIORAL MEDICINE; BEHAVIORAL SLEEP RESISTANCE TASK; CLINICAL FEATURE; COGNITIVE THERAPY; DAYTIME SOMNOLENCE; EPWORTH SLEEPINESS SCALE; EVENT RELATED POTENTIAL; FATIGUE; FATIGUE IMPACT SCALE; FATIGUE QUESTIONNAIRE; FATIGUE SEVERITY SCALE; HUMAN; HYPERSOMNIA; KAROLINSKA SLEEPINESS SCALE; MAINTENANCE OF WAKEFULNESS TEST; MAJOR DEPRESSION; MEASUREMENT; MULTIDIMENSIONAL FATIGUE INVENTORY; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; NONHUMAN; OXFORD SLEEP RESISTANCE TEST; PSYCHOMOTOR VIGILANCE TEST; RATING SCALE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP; SOMNOLENCE; STANDARD SLEEPINESS SCALE; VALIDATION PROCESS; VISUAL ANALOG SCALE; METHODOLOGY; SLEEP DISORDER;

BEHAVIORAL MEDICINE; FATIGUE; HUMANS; SLEEP DISORDERS;

EID: 77953722070     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Alloway C E D, Ogilvie RD, Shapiro CM. The alpha attenuation test: assessing excessive daytime sleepiness in narcolepsy-cataplexy. Sleep. 1997;20:258-66.
2. Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990;52(1-2): 29-37.
3. Anderson C, Platten CR, Horne JA. Self-reported 'sleep deficit' is unrelated to daytime sleepiness. Physiol Behav. 2009;96(4-5): 513-7.
4. Bailey A, Channon S, Beaumont JG. The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis. Mult Scler. 2007;13(1):73-80.
5. Balkin TJ, Bliese PD, Belenky G, Sing H, Thorne DR. et al. Comparative utility of instruments for monitoring sleepiness related performance decrements in the operational environment. J Sleep Res. 2004;13:219-27.
6. Banerjee D, Vitiello MV, Grunstein RR. Pharmacotherapy for excessive daytime sleepiness. Sleep Med Rev. 2004;8(5):339-54.
7. Bennett LS, Stradling JR, Davies R J O. A behavioural test to assess daytime sleepiness in obstructive sleep apnoea. J Sleep Res. 1997;6:142-5.
8. Baldwin DS, Papakostas GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry. 2006;67(6):9-15.
9. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28(4):464-71.
10. Borbély AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1(3):195-204.
11. Capuron L, Welberg L, Heim C, Wagner D, Solomon L. et al. Cognitive dysfunction relates to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology. 2006;31(8):1777-84.
12. Carroll JK, Kohli S, Mustian KM, Roscoe JA, Morrow GR. Pharmacologic treatment of cancer-related fatigue. Oncologist. 2007;12(1):43-51.
13. Chaumet G, Quera-Salva MA, Macleod A, Hartley S, Taillard J. et al. Is there a link between alertness and fatigue in patients with traumatic brain injury? Neurology, 2008;71(20):1609-13.
14. Cook DB, O'Connor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage. 2007;36(1):108-22.
15. Cooper MR, Bird HM, Steinberg M. Efficacy and safety of modafinil in the treatment of cancer-related fatigue. Ann Pharmacother. 2009;43(4):721-5.
16. Fava M. Pharmacological approaches to the treatment of residual symptoms. J Psychopharmacol. 2006;20(3 Suppl): 29-34.
17. Fisk JD, Ritvo PG, Ross L. et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. J Clin Infect Dis. 1994;18(suppl. 1): S79-S83.
18. Flachenecker P, Kümpfel T, Kallmann B, Gottschalk M, Grauer O. et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002;8(6):523-6.
19. Foley KF, DeSanty KP, Kast RE. Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006;6(9):1249-65.
20. Gosselin N, Mathieu A, Mazza S, Petit D, Malo J. et al. Attentional deficits in patients with obstructive sleep apnea syndrome: an event-related potential study. Clin Neurophysiol. 2006;117(10):2228-35.
21. Guilleminault C, Brooks SN. Excessive daytime sleepiness: a challenge for the practising neurologist. Brain. 2001;124(Pt 8):1482-91.
22. Hoddes E, Dement WC, Zarcone V. The development and use of the Stanford Sleepiness Scale. Psycho - physiology. 1972;9:150.
23. Hossain JL, Ahmad P, Reinish LW, Kayumov L
24. Hossain NK, Shapiro CM. Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res. 2005;14(3):245-53.
25. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-545.
26. Johns MW. Rethinking the assessment of sleepiness. Sleep Med Rev. 1998;2:3-15.
27. Johns MW. Sleep propensity varies with behaviour and the situation in which it is measured: the concept of somnificity. J Sleep Res. 2002;11(1):61-7.
28. Kaida K, Takahashi M, Akerstedt T, Nakata A, Otsuka Y. et al. Validation of the Karolinska sleepiness scale against performance and EEG variables. Clin Neurophysiol. 2006;117(7):1574-81.
29. Kasatkin DS, Spirin NN. Possible mechanisms of the formation of chronic fatigue syndrome in the clinical picture of multiple sclerosis. Neurosci Behav Physiol. 2007;37(3):215-9.
30. Kim H, Young T. Subjective daytime sleepiness: dimensions and correlates in the general population. Sleep. 2005;28(5):625-34.
31. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121-3.
32. Lange R, Volkmer M, Heesen C, Liepert J. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol. 2009;256(4):645-50.
33. Leger D. The cost of sleepiness. Sleep. 1995;18(4):281-4.
34. Leibowitz SM, Brooks SN, Black JE. Excessive daytime sleepiness: considerations for the psychiatrist. Psychiatr Clin North Am. 2006;29(4):921-45.
35. Leocani L, Colombo B, Comi G. Physiopathology of fatigue in multiple sclerosis. Neurol Sci. 2008;29(Suppl 2): S241-3.
36. Lerdal A, Wahl A, Rustøen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health. 2005;33(2):123-30.
37. Mairesse O, Neu D, Rosseel Y, VanAcker F, Cluydts R, Theuns P. Comparative sensitivity of outcome variables of a software-based Behavioral Sleep Resistance Task. Ind Health. 2009;47(1):80-8.
38. McKenna JT, Tartar JL, Ward CP, Thakkar MM, Cordeira JW. et al. Sleep fragmentation elevates behavioral, electrographic and neurochemical measures of sleepiness. Neuroscience. 2007;146(4):1462-73.
39. Meulemans A, Gerlo E, Seneca S, Lissens W, Smet J. et al. The aerobic forearm exercise test, a non-invasive tool to screen for mitochondrial disorders. Acta Neurol Belg. 2007;107(3):78-83.
40. Mitler MM, Gujavarty KS, Browman CP. Maitenance of wakefulness test: a polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolence. Electorencephalogr Clin Neurophysiol. 1982;53:658-61.
41. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B. et al. NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology. 2000;14(11 A): 151-61.
42. Monk TH. Subjective ratings of sleepiness - the underlying circadian mechanisms. Sleep. 1987;10:343-53.
43. Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol. 2005;10(2):245-59.
44. Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. 2009;2(1):1-16.
45. Neu D, Mairesse O, Hoffmann G, Dris A, Lambrecht LJ
46. Linkowski P, Verbanck P, Le Bon O. Sleep quality perception in the chronic fatigue syndrome. Correlations with sleep efficiency, affective symptoms and intensity of fatigue. Neuropsycho biology. 2007;56(1):40-46.
47. Neu D, Hoffmann G, Verbanck P, Linkowski P, Le Bon O. Are patients with chronic fatigue syndrome just 'tired' or also 'sleepy'? J Sleep Res. 2008;17(4):427-31.
48. Neu D, Pouchkina A, Peigneux P, Hoffmann G
49. Verbanck P, Linkowski P, Le Bon O. Cognitive impairment in fatigue and sleepiness associated conditions. Sleep. 2008;31(Suppl): 18.
50. Neu D, Cappeliez B, Hoffmann G, Verbanck P, Linkowski P, LeBon O. High slow wave sleep and low light sleep: the Chronic Fatigue Syndrome is not likely to be a primary sleep disorder. J Clin Neurophysiol. 2009;26(3):207-212.
51. Nutt DJ, Baldwin DS, Clayton AH, Elgie R, Lecrubier Y. et al. Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry. 2006;67(Suppl 6):46-9.
52. Ohayon MM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med. 2005;165(1):35-41.
53. Olson LG, Ambrogetti A, Sutherland DC. A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics. 2003;44(1):38-43.
54. Pawlikowska T, Chalder T, Hirsch SR, Wallace P, Wright DJ, Wessely SC. Population based study of fatigue and psychological distress. BMJ. 1994;308(6931):763-6.
55. Pigeon WR, Sateia MJ, Ferguson RJ. Distinguish - ing between excessive daytime sleepiness and fatigue: toward improved detection and treatment. J Psychosom Res. 2003;54(1):61-9.
56. Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev. 2008; (3): CD001027.
57. Sallinen M, Härmä M, Mutanen P, Ranta R, Virkkala J, Müller K. Sleepiness in various shift combinations of irregular shift systems. Ind Health. 2005;43(1):114-22.
58. Schmaling KB, Lewis DH, Fiedelak JI, Mahurin R, Buchwald DS. Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med. 2003;65(1):129-36.
59. Schulz H, Wilde-Frenz J, Grabietz-Kurfürst U. Cognitive deficits in patients with daytime sleepiness. Acta Neurol Belg. 1997;97(2):108-12.
60. Shen J, Barbera J, Shapiro CM. Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev. 2006;10(1):63-76.
61. Siessmeier T, Nix WA, Hardt J, Schreckenberger M, Egle UT, Bartenstein P. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry. 2003;74(7):922-8.
62. Stampi C, Stone P, Michimori A. A new quantitative method for assessing sleepiness: the alpha attenuation test. Work & Stress, 1995;9:368-76.
63. Stone P, Richards M, A'Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11(5):561-7.
64. Thorpy MJ. The clinical use of the multiple sleep latency test. Sleep. 1992;15:268-76.
65. Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K. et al. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial. Neurology. 2007;68(20):1680-6.
66. Vgontzas AN, Pejovic S, Zoumakis E, Lin HM, Bixler EO, Basta M, Fang J, Sarrigiannidis A, Chrousos GP. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes benificial changes in cortisol and interleukin-6 secretion. AM J Physiol Endocrinol Metab. 2007;292:253-261.